[{"Assets_0_Q3_USD":78600000.0,"CommonStockSharesOutstanding_0_Q3_shares":53935000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-13374000.0,"NetIncomeLoss_1_Q3_USD":-1988000.0,"NetIncomeLoss_3_Q3_USD":-10417000.0,"StockholdersEquity_0_Q3_USD":54773000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":16946000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":44526000.0,"Ticker":"CDXS","CIK":"1200375","name":"CODEXIS INC","OfficialName":"Codexis Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1143569916.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]